
|

|

|

Welcome to the Avoca Knowledge Center. Here you will find more in-depth
information about Avoca's services, philosophy, and client successes.
Up-to-Date Industry Insight View2010 Report Available for Purchase What does the Future Hold for CRO-Sponsor Relationships? View2009 Report Causes and Consequences of Mismatched Expectations View2008 Report Change Orders View2007 Report The FSP Model: Opportunities, Challenges, and TrendsView2006 Report Industry Practices and Perceptions View2005 Report Striking a Balance: Operations Role at the Bidding Stage of an Outsourced Project View2004 Report DIA 2011- 47th Annual MeetingViewJune 19-23, 2011 Chicago, IL Monday, June 20th 1:30 PM – Reducing Micro-management of CROs While Maintaining Effective Quality Oversight: Results from a 2011 Industry Survey Denise Calaprice-Whitty, PhD, MS, Executive Director, The Avoca Group Panel Members John G. Harkins, MBA, Otsuka Wayne Langlois, Covance Winifred Ann Meeker-O’Connell, MS, FDA Tuesday, June 21st 10 AM - Committing to Two Partners: A Look at a Strategic CRO Sourcing Initiative Joan C. Millsaps, MSN, RN, Bristol-Myers Squibb Panel Members Lisa McKay, MBA, The Avoca Group Bari Kowal, MS, ICON Joshua Schultz, PAREXEL 1:30 PM – An Innovative Strategic Partnering Relationship: Can This Approach Revolutionize Drug Development? Solomon Babani, MBA, Celtic Therapeutics Panel Members Kerry Toone, PPD Patricia Leuchten, The Avoca Group Wednesday, June 22nd 1:30 PM – A Close Look at Clinical Outsourcing Strategies: An Executive Roundtable Patricia Leuchten, The Avoca Group Panel Members Peter A. Carberry, MD, MBA, Astellas Mitchell A. Katz, PhD, Purdue Pharma Craig Coffman, Endo Pharmaceuticals
Partnerships in Clinical TrialsViewMarch 30 - April 1, 2011 Phoenix, Arizona Please join The Avoca Group at the following PCT Events in Arizona:
Wednesday, March 30th 2:15 PM– A Sponsor Outsourcing Dilemma: Reducing Micro-Management of CROs while maintaining Effective Quality Oversite Panel Members: Wayne Langlois, VP/GM Americas, Covance Peter Carberry, MD, Senior VP Global Development Operations, Astellas John Oidtman, VP Clinical Operations-Emerging Markets, Pfizer Friday, April 1st 8:00 AM – Market Insight Roundtable Discussion Janice Hutt, Chief Operating Office of The Avoca Group will moderate a discussion surrounding findings on the state of clinical outsourcing in 2011 and what this means for both sponsors and clinical services providers both now and going forward as the industry changes. 11:00 AM – Commitment to Two Partners - A Look at the BMS Integrated Strategic Sourcing Initiative Panel Members: Joan Milsaps, Director, Business Operations & Outsourcing Mgmt, Bristol-Myers Squibb Cynthia Hauck, Associate Director, Outsourcing Mgmt, Bristol-Myers Squibb Bari Kowal, VP of Strategic Programs & Mgmt, ICON Joshua Schultz, VP, Strategic Account Leader, PAREXEL
3:30 PM - Post Conference Session:The State of Clinical Outsourcing Dr. Denise Calaprice-Whitty, Senior Director, The Avoca Group will present the results from the 2011 Avoca Industry Survey, The State of Clinical Outsourcing, which explores outsourcing relationships, trends, practices and approaches, and in particular, how these vary according to the type and size of sponsor company.
Filling in the Bigger Picture- Pharmaceutical Executive June 2011Authored by Lisa McKay, Jackie Syrop and Dr. Denise Calaprise-WhittyViewWomen in Business- Management Today March 2011Authored by Chris PetersonViewThis Management Today special feature focuses on today's women executives and their opportunities and challenges. The Future of Clinical Service Provider-Sponsor Relationships- Pharmaceutical Technology February 2011Authored by Denise Calaprice-WhittyViewThe author analyzes the results of a survey that polled pharmaceutical executives and managers about both sides of the outsourcing relationship.
Do CROs Help?ViewAs part of ClinPage's Clinical Efficiency Series, this article discusses the efficiency of outsourcing relationships.
Partnerships 2010: What Does the Future Hold for Sponsor-Clinical Service Provider Relationships? Authored by Partnerships in Clinical TrialsViewDuring a presentation at Partnerships in Clinical Trials 2010, The Avoca Group shared data and key findings from their annual survey and used that data as a catalyst for the panel discussion. The focus of the survey and the question posed to respondents was “ How has outsourcing strategy changed over the last 5 years?” Both Sponsors and CROs were polled and the data correlated to find synergies and separations in expectations in outsourcing relationships. The State of Clinical Outsourcing- Applied Clinical Trials Online March 2010Authored by Denise Calaprice-WhittyViewThis article, in the March 2010 edition of Applied Clinical Trials Online, is exploring an in-depth survey revealing trends, outlooks, and future plans of both sponsors and service providers.
Does Size Matter in PartnershipsAuthored by Marissa ShapiroViewWith size as an influence, do sponsors seek out similar sized providers? Mismatched Expectations Between Sponsors and Service Providers - The Monitor February 2009Authored by Denise Calaprice-WhittyViewThis article, published in the February 2009 edition of The Monitor, describes a survey that focused on the causes and consequences of mismatched expectations between sponsors and clinical service providers.
The State of Clinical Outsourcing - The Monitor February 2008Authored by Patricia Leuchten and Denise Calaprice-Whitty ViewThis article, published in the 2008 edition of The Monitor, reviews the results from the Avoca 2007 Industry Survey.
Pre-Survey MethodologyAuthored by Hugh F. Cline, Ph.D.ViewSample ReportsViewWhite Paper: Survey Research and Relationship ManagementViewCase StudyViewThe Preferred Provider Tug-of-WarAuthored by Patricia LeuchtenViewWhite Paper: Survey Research and Relationship ManagementAuthored by Hugh F. Cline, Ph.D.ViewCase StudyViewClient Relationship LifecycleViewCRO Client Feedback/Sample DataViewCase StudyViewHow to Avoid the Six “Black Holes” that Undermine CRO Assessment InitiativesAuthored by Patricia LeuchtenViewCase StudyViewMedical Safety Data Assessment and Reporting in the Pharmaceutical and Biotechnology Industries - High Risk, Labor Intensive Work: When is Outsourcing a Viable Solution?Authored by Zel Dolinsky, Ph.D.View
|

|

|

|

"They come to the table with lots of ideas and contribute to the
conversation, but they're also great listeners."
Ken Newport
Senior Vice President
PRA International

|

|